Glüer C C
Arbeitsgruppe Medizinische Physik, Klinik für Diagnostische Radiologie, Universitätsklinikum Kiel, Kiel, Germany.
Baillieres Best Pract Res Clin Endocrinol Metab. 2000 Jun;14(2):195-211. doi: 10.1053/beem.2000.0069.
Bone densitometry is an established method for the assessment of osteoporosis as, according to the definition of osteoporosis, an accurate determination of the level of bone mass is central to the diagnostic assessment of osteoporosis. The diversity of different bone densitometry techniques, however, needs to be acknowledged. The World Health Organization criteria of osteoporosis should not be used for peripheral measurements, and their application to subject groups other than white women is still controversial. A large variety of bone densitometry and quantitative ultrasound techniques can be used for fracture risk assessment. Their results should be interpreted in the context of other clinical examinations and can then be used in making treatment decisions. For monitoring purposes, the ratio of response rate and long-term precision error determines longitudinal sensitivity. For all of these applications, careful quality assurance procedures need to be implemented. If applied in a responsible fashion, bone densitometry represents a powerful approach that is indispensable for the assessment of osteoporosis.
骨密度测定是评估骨质疏松症的既定方法,因为根据骨质疏松症的定义,准确测定骨量水平是骨质疏松症诊断评估的核心。然而,需要认识到不同骨密度测定技术的多样性。世界卫生组织的骨质疏松症标准不适用于外周测量,将其应用于白人女性以外的其他受试者群体仍存在争议。多种骨密度测定和定量超声技术可用于骨折风险评估。其结果应结合其他临床检查进行解读,然后可用于制定治疗决策。为了进行监测,反应率与长期精密度误差的比值决定了纵向敏感性。对于所有这些应用,都需要实施严格的质量保证程序。如果以负责任的方式应用,骨密度测定是一种强大的方法,对于骨质疏松症的评估不可或缺。